Pfizer announced it will supply 200 million doses of its COVID-19 vaccine for the U.S. by the end of May and is aiming to ship 2 billion doses globally this year. The vaccine is over 90% effective according to clinical trials conducted in 2020, but more testing needs to be done to see how well it protects against the new variants. Dr. Phil Dormitzer, who helped develop the vaccine as vice president and chief scientific officer of viral vaccines at Pfizer, joins CBSN to discuss.
CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the CBS All Access subscription service.
Subscribe to the CBS News YouTube channel: [ Ссылка ]
Watch CBSN live: [ Ссылка ]
Download the CBS News app: [ Ссылка ]
Follow CBS News on Instagram: [ Ссылка ]
Like CBS News on Facebook: [ Ссылка ]
Follow CBS News on Twitter: [ Ссылка ]
Subscribe to our newsletters: [ Ссылка ]
Get new episodes of shows you love across devices the next day, stream CBSN and local news live, and watch full seasons of CBS fan favorites like Star Trek Discovery anytime, anywhere with CBS All Access. Try it free: [ Ссылка ]
